Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Aldosterone modulates endothelial permeability and endothelial nitric oxide synthase activity by rearrangement of the actin cytoskeleton.

Kirsch T, Beese M, Wyss K, Klinge U, Haller H, Haubitz M, Fiebeler A.

Hypertension. 2013 Feb;61(2):501-8. doi: 10.1161/HYPERTENSIONAHA.111.196832. Epub 2012 Dec 3.

PMID:
23213194
2.

Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity.

Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, Hirata Y, Naruse M.

Hypertension. 2006 Jul;48(1):165-71. Epub 2006 Jun 5.

PMID:
16754797
3.

[Tumor necrosis factor-α promote permeability of human umbilical vein endothelial cells via activating RhoA-ERK1/2 pathway].

Yan CH, Yu HB, Huang MF, Li J, Zhang XL, Han YL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jun;39(6):531-7. Chinese.

PMID:
21924080
4.

Intracellular Ascorbate Prevents Endothelial Barrier Permeabilization by Thrombin.

Parker WH, Qu ZC, May JM.

J Biol Chem. 2015 Aug 28;290(35):21486-97. doi: 10.1074/jbc.M115.662098. Epub 2015 Jul 7.

5.

Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase.

Aslam M, Schluter KD, Rohrbach S, Rafiq A, Nazli S, Piper HM, Noll T, Schulz R, Gündüz D.

J Physiol. 2013 Jan 15;591(2):461-73. doi: 10.1113/jphysiol.2012.237834. Epub 2012 Oct 22.

6.

Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.

Gonzales JN, Kim KM, Zemskova MA, Rafikov R, Heeke B, Varn MN, Black S, Kennedy TP, Verin AD, Zemskov EA.

Vascul Pharmacol. 2014 Aug;62(2):63-71. doi: 10.1016/j.vph.2014.01.005. Epub 2014 Jan 25.

7.

Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.

Cui H, Okamoto Y, Yoshioka K, Du W, Takuwa N, Zhang W, Asano M, Shibamoto T, Takuwa Y.

J Allergy Clin Immunol. 2013 Nov;132(5):1205-1214.e9. doi: 10.1016/j.jaci.2013.07.026. Epub 2013 Sep 8.

PMID:
24021572
8.

Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction.

Allen C, Srivastava K, Bayraktutan U.

Stroke. 2010 Sep;41(9):2056-63. doi: 10.1161/STROKEAHA.109.574939. Epub 2010 Jul 22.

PMID:
20651275
9.

HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption.

Wolfson RK, Chiang ET, Garcia JG.

Microvasc Res. 2011 Mar;81(2):189-97. doi: 10.1016/j.mvr.2010.11.010. Epub 2010 Dec 10.

10.

RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.

Clements RT, Minnear FL, Singer HA, Keller RS, Vincent PA.

Am J Physiol Lung Cell Mol Physiol. 2005 Feb;288(2):L294-306. Epub 2004 Oct 8.

11.
13.

Radiation effects on the cytoskeleton of endothelial cells and endothelial monolayer permeability.

Gabryś D, Greco O, Patel G, Prise KM, Tozer GM, Kanthou C.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1553-62. Epub 2007 Oct 24.

PMID:
17920784
14.

Stem cell factor is a potent endothelial permeability factor.

Kim JY, Choi JS, Song SH, Im JE, Kim JM, Kim K, Kwon S, Shin HK, Joo CK, Lee BH, Suh W.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1459-67. doi: 10.1161/ATVBAHA.114.303575. Epub 2014 May 1.

PMID:
24790137
15.

[Serum response factor participates in RhoA-induced endothelial cell F-actin rearrangements].

Han YL, Yu HB, Yan CH, Meng ZM, Zhang XL, Kang J, Li SH, Wang SW.

Sheng Li Xue Bao. 2005 Jun 25;57(3):295-302. Chinese.

16.

Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms.

Hirase T, Kawashima S, Wong EY, Ueyama T, Rikitake Y, Tsukita S, Yokoyama M, Staddon JM.

J Biol Chem. 2001 Mar 30;276(13):10423-31. Epub 2001 Jan 3.

17.

Rho and Rac but not Cdc42 regulate endothelial cell permeability.

Wójciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ.

J Cell Sci. 2001 Apr;114(Pt 7):1343-55.

18.

Aldosterone enhances ligand-stimulated nitric oxide production in endothelial cells.

Mutoh A, Isshiki M, Fujita T.

Hypertens Res. 2008 Sep;31(9):1811-20. doi: 10.1291/hypres.31.1811.

PMID:
18971560
19.

Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.

Pojoga LH, Romero JR, Yao TM, Loutraris P, Ricchiuti V, Coutinho P, Guo C, Lapointe N, Stone JR, Adler GK, Williams GH.

Endocrinology. 2010 Mar;151(3):1236-46. doi: 10.1210/en.2009-0514. Epub 2010 Jan 22.

20.

Regulation of the RhoA pathway in human endothelial cell spreading on type IV collagen: role of calcium influx.

Masiero L, Lapidos KA, Ambudkar I, Kohn EC.

J Cell Sci. 1999 Oct;112 ( Pt 19):3205-13.

Supplemental Content

Support Center